Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The European Organisation for Research and Treatment of Cancer: Module Development for Metastatic Breast Cancer (Phase I-IIIa/b)

NCT07806266 is registered in ClinicalTrials.gov with University of Leeds as lead sponsor.

NCT NCT07806266
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07806266 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The European Organisation for Research and Treatment of Cancer: Module Development for Metastatic Breast Cancer (Phase I-IIIa/b)
Lead sponsor
University of Leeds
Phase
Observational
Overall status
Recruiting
Start date
May 1, 2020
Completion date
May 31, 2029
Enrollment
568 (estimated)
Sites
22

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic beast cancer